Skip to main content
Wiley Open Access Collection logoLink to Wiley Open Access Collection
. 2026 May 7;604(14):5694–5697. doi: 10.1113/JP291339

Is oxysterol accumulation a central physiological trigger of inflammaging?

Nila Ganamurali 1, Sarvesh Sabarathinam 1,✉
PMCID: PMC13370686  PMID: 42097696

Ageing is accompanied by a progressive disruption of lipid homoeostasis characterized by a declining cholesterol‐to‐oxysterol ratio. Oxidative stress–driven accumulation of bioactive oxysterols, particularly 7‐ketocholesterol (7‐KC), emerges as a central driver of cellular dysfunction during ageing. Age‐associated impairment of cytochrome P450–mediated detoxification and ATP‐binding cassette transporter dependent sterol efflux promotes oxysterol retention, triggering endoplasmic reticulum stress, mitochondrial failure, inflammasome activation and senescence‐associated secretory phenotypes. These events converge on chronic sterile inflammation, or inflammaging, linking lipid oxidation to atherosclerosis, neurodegeneration and tissue degeneration. Oxysterols thus function as integrative molecular nodes connecting redox imbalance to systemic ageing physiology.

Oxidative lipid remodelling and oxysterol accumulation in ageing

Ageing involves the progressive decline in physiological functions, marked by metabolic disruptions like shifts in the lipidome, where the cholesterol to oxysterol ratio decreases, promoting pathology (Ashique et al., 2026). Oxidative stress causes oxysterols, which are products of oxidized cholesterol, to build up and disturb cellular equilibrium. In addition to biosynthesis oxysterol clearance plays a critical role in maintaining sterol homoeostasis. Oxysterols are eliminated via hepatic conversion to bile acids, sulfation by SULT enzymes and efflux through ABC transporters. Ageing impairs these clearance pathways through reduced hepatic function, transporter downregulation and diminished enzymatic detoxification, thereby exacerbating systemic oxysterol accumulation and prolonging their pro‐inflammatory effects (de Medina, Silvente‐Poirot, & Poirot, 2022). In age‐related diseases such as atherosclerosis, Alzheimer's disease and macular degeneration this changed ratio causes inflammation, mitochondrial malfunction and cell death (Kakkar et al., 2025; Kakkar, Singh, Jasoria, et al., 2026; Kakkar, Singh, Singh, et al., 2026). In addition to keeping membranes fluid cholesterol is a precursor of bile acids and hormones. Autoxidation or enzymatic conversion to bioactive oxysterols such as 7‐ketocholesterol (7‐KC) is made possible by its Δ5 double bond (S, 2026; Sukumaran & S, 2026; Vejux et al., 2025; Zarrouk et al., 2014). Oxysterols are enzymatically generated via cytochrome P450 (CYP) enzymes, such as CYP46A1, CYP27A1 and CYP7A1, acting as ligands for Liver X Receptor (LXR) to promote cholesterol efflux and Sterol Regulatory Element‐Binding Protein(SREBP) inhibition via Insight, thus maintaining lipid balance through reactive oxygen species (ROS) induced downregulation and transcriptional alterations; ageing reduces CYP activity and detoxification by enzymes such as CYP3A and CYP7. Increased ROS causes non‐enzymatic oxidation at the C5–C6 link of cholesterol, producing highly cytotoxic oxysterols, including 25‐hydroxycholesterol and 7‐KC. These derivatives trigger endoplasmic reticulum (ER) stress, NLRP3 inflammasome activation and senescence‐associated secretory phenotype (SASP), fuelling chronic low‐grade inflammation (‘inflammaging’) and degeneration in tissues like brain, vasculature and liver (Brown, Sharpe, & Rogers, 2021; Gargiulo, Gamba, Testa, Leonarduzzi, & Poli, 2016). The age‐related decline in ABCA1 and ABCG1 transporters impairs sterol efflux, leading to oxysterol build‐up in macrophages and endothelial cells, which promotes foam cell formation and vascular pathology. In addition to ROS reactive nitrogen species (RNS) and reactive sulphur species (RSS) play a complex role in oxysterol biology. Through nitrosative alterations and peroxynitrite production, nitric oxide (NO) controls oxysterol signalling and cholesterol oxidation via endothelial and inducible nitric oxide synthases (eNOS/iNOS). One important RSS, hydrogen sulphide (H2S), affects ABCA1‐mediated efflux and CYP enzyme activity to regulate cholesterol homoeostasis. Additionally oxysterols are positioned within a larger redox network that drives inflammation when redox enzymes such as myeloperoxidase integrate ROS–RNS–RSS crosstalk, enhancing lipid oxidation and inflammatory signalling (Brahmi et al., 2025; Wu, Hu, & Zhu, 2018). To facilitate reverse cholesterol transport (RCT) to the liver for excretion ABCA1 and ABCG1 mediate the ATP‐dependent export of cholesterol and oxysterols to apoA‐I and high‐density lipoprotein (HDL). These transporters are upregulated in young cells by LXR activation, which preserves lipid homoeostasis; however as cells age their expression is decreased due to ROS‐mediated damage and epigenetic silencing (Bazioti et al., 2022; Matsuo, 2022). Table 1 discusses the oxysterol‐mediated molecular mechanisms driving ageing and inflammaging.

Table 1.

Oxysterol‐mediated molecular mechanisms driving ageing and inflammaging

Oxysterol Primary source Key molecular targets/pathways Cellular consequences Age‐related pathologies
7‐KC ROS‐mediated cholesterol oxidation PERK–CHOP, NLRP3 inflammasome, lysosomal membranes, Bax/Bak ER stress, mitochondrial dysfunction, oxiapoptophagy, pyroptosis Atherosclerosis, Alzheimer's disease, AMD
25‐Hydroxycholesterol Non‐enzymatic oxidation; immune activation LXR, SREBP inhibition, NF‐κB Inflammation, sterol efflux dysregulation Inflammaging, neurodegeneration
27‐Hydroxycholesterol CYP27A1‐mediated oxidation LXR activation, mitochondrial stress Altered lipid signalling, ROS amplification Vascular ageing, metabolic dysfunction
24S‐Hydroxycholesterol CYP46A1 (brain‐specific) LXR, cholesterol clearance Neurotoxicity at high levels Alzheimer's disease
Mixed oxysterols Ageing lipidome ABCA1/ABCG1 suppression Foam cell formation, endothelial dysfunction Plaque instability, thrombosis

Note: Oxysterol accumulation reflects an age‐dependent imbalance between CYP‐mediated detoxification, oxidative generation and ABC transporter‐dependent efflux.

Abbreviations: AMD, age‐related macular degeneration; CYP, cytochrome P450; ER, endoplasmic reticulum; ROS, reactive oxygen species; LXR‐Liver X Receptor, SREBP‐Sterol Regulatory Element‐Binding Protein.

Oxysterol‐induced foam cell formation, endothelial dysfunction and oxiapoptophagy in ageing

In senescent macrophages diminished efflux causes intracellular lipid droplets rich in cytotoxic oxysterols such as 7‐KC, triggering ER stress, inflammasome activation and foam cell differentiation hallmarks of atherosclerosis and ‘inflammaging’. Endothelial dysfunction follows, with impaired barrier integrity and pro‐thrombotic shifts. In senescent macrophages impaired cholesterol efflux fosters lipid‐laden droplets rich in cytotoxic oxysterols such as 7‐KC, which provoke ER stress via PERK/CHOP activation, NLRP3 inflammasome signalling and foam cell differentiation central to atherosclerotic plaque instability and ‘inflammaging’. This macrophage pathology extends to adjacent endothelium, eliciting oxidative insult that erodes barrier function through ICAM‐1 overexpression and MAPK cascades, while instigating a pro‐thrombotic state marked by tissue factor (TF) induction and blunted vasodilatation (Gajendran, Ganamurali, & Sabarathinam, 2025). Oxiapoptophagy, a term coined by Nury et al. (2021), encapsulates the hybrid cell death modality triggered predominantly by 7‐KC, fusing oxidative stress (oxi‐), apoptotic signalling (apopto‐) and defective autophagy (‐phagy)(Nury et al., 2021).

7‐KC induced autophagy blockade and oxiapoptophagy

To prevent autophagosome lysosome fusion and produce undegraded payloads 7‐KC embeds into lysosomal membranes, neutralizing acid hydrolases (such as cathepsin D) and raising intralysosomal pH. By impairing mitophagy this autophagic blockade increases ROS and fuels peroxide‐mediated oxidation of lipids, proteins and mitochondrial DNA (mtDNA). It also triggers caspase‐independent apoptosis by MPT pore opening and Bax/Bak oligomerization. The ‘clogging’ precipitates mitochondrial hyperfusion, bioenergetic collapse (ΔΨm loss) and cytosolic translocation of lysosomal enzymes, culminating in hybrid oxiapoptophagy distinct from classical apoptosis or ferroptosis by its autophagy dependence. In ageing contexts this manifests in foam cells and neurons, linking to plaque rupture and neurodegeneration (Ghzaiel, Nury, Zarrouk, Vejux, & Lizard, 2022).

Oxysterols as endogenous DAMPs: NLRP3 inflammasome activation and inflammaging

As strong endogenous danger signals (DAMPs), oxysterols, especially 7‐KC, pharmacologically stimulate and activate the NLRP3 inflammasome in aged cells, increasing sterile inflammation. In LPS‐sensitized macrophages and retinal pigment epithelial (RPE) cells 7‐KC first upregulates NLRP3 and pro‐IL‐1β/IL‐18 via NF‐κB priming; subsequent lysosomal instability causes K+ efflux, ASC oligomerization and caspase‐1 autoactivation. This drives pyroptosis and SASP amplification, which are essential for ‘inflammaging’ in atherosclerosis, age‐related macular degeneration (AMD) and neurodegeneration. It also cleaves pro‐cytokines into mature interleukin 1β (IL‐1β) and IL‐18 (Indaram et al., 2015; Xiang Li et al., 2014; Martins, Ferreira, Palotás, Rocha, & Reis, 2023; Shi et al., 2015). Pro‐IL‐1β and pro‐IL‐18 are proteolytically cleaved by activated caspase‐1 into their physiologically active counterparts, IL‐1β and IL‐18, which are then released to increase systemic and paracrine inflammation. A hallmark of inflammasome activation, this cytokine maturation stage directly aids in the spread of SASP as people age (Barker, Taxman, & Ting, 2011; Xia Li et al., 2023).

Oxysterols as central integrators of ageing pathophysiology

Ageing is driven by progressive disruption of cholesterol homeostasis, marked by a shift towards oxysterol accumulation under oxidative stress. Declining CYP‐mediated detoxification and impaired ABCA1/ABCG1 efflux promote the retention of cytotoxic oxysterols, particularly 7‐KC, across ageing tissues. These lipotoxic metabolites induce ER stress, mitochondrial dysfunction, inflammasome activation and a hybrid cell death programme termed oxiapoptophagy, reinforcing cellular senescence and inflammaging. By acting as endogenous danger signals oxysterols integrate redox imbalance with chronic sterile inflammation and degenerative pathology. Targeting oxysterol generation, signalling or clearance represents a promising pharmacological strategy to mitigate age‐associated metabolic, vascular and neurodegenerative disorders. Therapeutically strategies to reduce oxysterol burden include the inhibition of cholesterol oxidation (e.g. antioxidants targeting lipid peroxidation), enhancement of sterol efflux via LXR agonists and promotion of enzymatic detoxification through CYP modulation. Emerging approaches also include nanoparticle‐based delivery systems and sulfation‐enhancing strategies to accelerate oxysterol clearance, representing promising interventions to attenuate inflammaging.

Conclusion

Oxysterols emerge as pivotal molecular intermediates in the physiology of ageing, translating oxidative stress into chronic inflammation, cellular senescence and tissue degeneration. Age‐related impairment of sterol detoxification and efflux transforms oxysterols from regulatory lipid mediators into cytotoxic drivers of oxiapoptophagy and inflammasome activation. By integrating redox imbalance, lipid signalling and innate immune activation oxysterols provide a unifying framework for understanding inflammaging and age‐associated diseases. Targeting oxysterol generation, trafficking or signalling may therefore represent a promising strategy to restore lipid homoeostasis and mitigate degenerative ageing phenotypes. This expanded redox‐centric framework positions oxysterols not merely as lipid by‐products but as dynamic integrators of ROS–RNS–RSS signalling networks in ageing biology.

Additional information

Competing interests

None.

Author contributions

N.G., S.S.: conceptualization, visualization, software, validation, writing – reviewing and editing. Both authors contributed equally.

Funding

No funding was received for this study

Supporting information

Peer Review History

TJP-604-5694-s001.pdf (914KB, pdf)

Handling Editors: Kim Barrett & Vaughan Macefield

The peer review history is available in the Supporting Information section of this article (https://doi.org/10.1113/JP291339#support‐information‐section).

References

  1. Ashique, S. , Islam, A. , Kumar, P. , Selim, S. , Al Jaouni, S. K. , Chakraborty, A. , Kahwa, I. , Goyal, R. , Chopra, S. , & Chopra, H. (2026). Neuro‐protective potential of honey: A narrative review. Current Pharmaceutical Design, 32(12), 901–917. [DOI] [PubMed] [Google Scholar]
  2. Barker, B. R. , Taxman, D. J. , & Ting, J. P. (2011). Cross‐regulation between the IL‐1β/IL‐18 processing inflammasome and other inflammatory cytokines. Current Opinion in Immunology, 23(5), 591–597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bazioti, V. , La Rose, A. M. , Maassen, S. , Bianchi, F. , de Boer, R. , Halmos, B. , Dabral, D. , Guilbaud, E. , Flohr‐Svendsen, A. , Groenen, A. G. , Marmolejo‐Garza, A. , Koster, M. H. , Kloosterhuis, N. J. , Havinga, R. , Pranger, A. T. , Langelaar‐Makkinje, M. , de Bruin, A. , van de Sluis, B. , Kohan, A. B. , … Westerterp, M. (2022). T cell cholesterol efflux suppresses apoptosis and senescence and increases atherosclerosis in middle aged mice. Nature Communications, 13(1), 3799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brahmi, F. , Mackrill, J. J. , Ghzaiel, I. , Rezig, L. , Benkhalifa, R. , Zarrouk, A. , Jouanny, P. , Vejux, A. , & Lizard, G. (2025). Oxysterol‐induced inflammation in Human diseases: Strategies for treatment with natural compounds and synthetic molecules. Molecules, 30(13), 2883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brown, A. J. , Sharpe, L. J. , & Rogers, M. J. (2021). Oxysterols: From physiological tuners to pharmacological opportunities. British Journal of Pharmacology, 178(16), 3089–3103. [DOI] [PubMed] [Google Scholar]
  6. de Medina, P. , Silvente‐Poirot, S. , & Poirot, M. (2022). Oxysterols are potential physiological regulators of ageing. Ageing Research Reviews, 77, 101615. [DOI] [PubMed] [Google Scholar]
  7. Gajendran, T. Y. , Ganamurali, N. , & Sabarathinam, S. (2025). 7‐Ketocholesterol: A pathogenic oxysterol in atherosclerosis and lysosomal storage disorders – Molecular insights and clinical implications. Journal of Steroid Biochemistry and Molecular Biology, 252, 106797. [DOI] [PubMed] [Google Scholar]
  8. Gargiulo, S. , Gamba, P. , Testa, G. , Leonarduzzi, G. , & Poli, G. (2016). The role of oxysterols in vascular ageing. The Journal of Physiology, 594(8), 2095–2113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Ghzaiel, I. , Nury, T. , Zarrouk, A. , Vejux, A. , & Lizard, G. (2022). Oxiapoptophagy in age‐related diseases. Comment on Ouyang et al. 7‐ketocholesterol induces Oxiapoptophagy and inhibits osteogenic differentiation in MC3T3‐E1 cells. Cells 2022, 11, 2882. Cells, 11(22), 3612. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Indaram, M. , Ma, W. , Zhao, L. , Fariss, R. N. , Rodriguez, I. R. , & Wong, W. T. (2015). 7‐ketocholesterol increases retinal microglial migration, activation and angiogenicity: A potential pathogenic mechanism underlying age‐related macular degeneration. Scientific Reports, 5(1), 9144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kakkar, A. , Singh, H. , Jasoria, Y. , Kumar, A. , Chopra, S. , Chopra, H. , & Mishra, A. K. (2026). Bridging pathologies: Mechanistic insights into the diabetes–Alzheimer's nexus. EXCLI Journal, 25, 261–289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kakkar, A. , Singh, H. , Singh, B. K. , Chauhan, K. , Chopra, S. , Chopra, H. , & Mishra, A. K. (2026). Molecular mechanisms of aging in the pathogenesis of Alzheimer's disease. Discover Neuroscience, 21(1), 13. [Google Scholar]
  13. Kakkar, A. , Singh, H. , Singh, B. K. , Kumar, A. , Mishra, A. K. , & Chopra, H. (2025). Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms. Journal of Alzheimer's Disease, 108(1), 19–41. [DOI] [PubMed] [Google Scholar]
  14. Li, X. , Li, C. , Zhang, W. , Wang, Y. , Qian, P. , & Huang, H. (2023). Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduction and Targeted Therapy, 8(1), 239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Li, X. , Zhang, Y. , Xia, M. , Gulbins, E. , Boini, K. M. , & Li, P.‐L. (2014). Activation of Nlrp3 inflammasomes enhances macrophage lipid‐deposition and migration: Implication of a novel role of inflammasome in atherogenesis. PLoS ONE, 9(1), e87552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Martins, G. L. , Ferreira, C. N. , Palotás, A. , Rocha, N. P. , & Reis, H. J. (2023). Role of oxysterols in the activation of the NLRP3 inflammasome as a potential pharmacological approach in Alzheimer's disease. Current Neuropharmacology, 21(2), 202–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Matsuo, M. (2022). ABCA1 and ABCG1 as potential therapeutic targets for the prevention of atherosclerosis. Journal of Pharmacological Sciences, 148(2), 197–203. [DOI] [PubMed] [Google Scholar]
  18. Nury, T. , Zarrouk, A. , Yammine, A. , Mackrill, J. J. , Vejux, A. , & Lizard, G. (2021). Oxiapoptophagy: A type of cell death induced by some oxysterols. British Journal of Pharmacology, 178(16), 3115–3123. [DOI] [PubMed] [Google Scholar]
  19. S, A. N. (2026). Targeting 7‐ketocholesterol–driven metabolic dysfunction in obesity: Therapeutic potential of bifidobacterium and dietary antioxidants. The Journal of Steroid Biochemistry and Molecular Biology, 260, 106998. [DOI] [PubMed] [Google Scholar]
  20. Shi, G. , Chen, S. , Wandu, W. S. , Ogbeifun, O. , Nugent, L. F. , Maminishkis, A. , Miller, J. L. , Mahdi, R. M. , & Gery, I. (2015). Inflammasomes induced by 7‐ketocholesterol and other stimuli in RPE and in bone marrow‐derived cells differ markedly in their production of IL‐1β and IL‐18. Investigative Ophthalmology & Visual Science, 56(3), 1658–1664. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sukumaran, E. S. , & S, A. N. (2026). Why 7‐ketocholesterol matters now: A rapid review of its pathogenic and therapeutic relevance. Journal of Steroid Biochemistry and Molecular Biology, 255, 106865. [DOI] [PubMed] [Google Scholar]
  22. Vejux, A. , Ghzaiel, I. , Mackrill, J. J. , Dias, I. H. K. , Rezig, L. , Ksila, M. , Zarrouk, A. , Nury, T. , Brahmi, F. , El Midaoui, A. , Meziane, S. , Atanasov, G. A. , Hammami, S. , Latruffe, N. , Jouanny, P. , & Lizard, G. (2025). Oxysterols, age‐related‐diseases and nutritherapy: Focus on 7‐ketocholesterol and 7β‐hydroxycholesterol. Prostaglandins & Other Lipid Mediators, 178, 106993. [DOI] [PubMed] [Google Scholar]
  23. Wu, D. , Hu, Q. , & Zhu, D. (2018). An update on hydrogen sulfide and nitric oxide interactions in the cardiovascular system. Oxidative Medicine and Cellular Longevity, 2018, 4579140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Zarrouk, A. , Vejux, A. , Mackrill, J. , O'Callaghan, Y. , Hammami, M. , O'Brien, N. , & Lizard, G. (2014). Involvement of oxysterols in age‐related diseases and ageing processes. Ageing Research Reviews, 18, 148–162. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Peer Review History

TJP-604-5694-s001.pdf (914KB, pdf)

Articles from The Journal of Physiology are provided here courtesy of Wiley

RESOURCES